Guru Ownership Trend
Guru Analysis for Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $400.43 M.
Top institutional holders include Cliff Asness and Renaissance Technologies.
Institutional sentiment is currently Bullish. This is evidenced by a $47.17 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, HOTCHKIS & WILEY reduced exposure by 13.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Jazz Pharmaceuticals plc (JAZZ)
Major holders include Cliff Asness ($149.14 M), Renaissance Technologies ($142.25 M), Steven Cohen ($29.75 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.1 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $47.17 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited JAZZ. The total reported sell value was $18.23 M.
Yes, 2 managers opened new positions in JAZZ, and 3 increased their existing holdings. The total reported buy value was $65.4 M.
